Advances in gastrointestinal vascular bleeding disorders: Successful sirolimus treatment in colonic angioectasia

Qi Sun1, Xiao-Ying Wang1,2, Dong-Hao Li1

  • 1Department of Gastroenterology, Air Force Medical Center, Beijing 100142, China.

PubMed

Insights

Research on gastrointestinal vascular bleeding disorders shows a trend towards pharmacological treatments, like sirolimus for angiodysplasia, improving patient outcomes. This shift offers new management strategies for these challenging conditions.

Area of Science:

  • Gastroenterology and Hepatology
  • Vascular Medicine
  • Bibliometrics and Research Trends

Background:

  • Gastrointestinal (GI) vascular bleeding disorders present complex clinical challenges with varied treatment responses.
  • Optimal management strategies for these conditions are still evolving, necessitating ongoing research.
  • Existing diagnostic and therapeutic techniques require further refinement.

Purpose of the Study:

  • To analyze research trends and clinical advancements in GI vascular bleeding disorders.
  • To identify key themes and therapeutic progress in the field.
  • To evaluate the evolving landscape of GI vascular bleeding disorder management.

Main Methods:

  • Bibliometric analysis of 470 scholarly articles (2000-2024) from the Web of Science Core Collection.
  • Identification of publication trends, high-frequency keywords, and leading research institutions.
  • Case study illustrating sirolimus efficacy in managing refractory colonic angioectasia.

Main Results:

  • The United States led publications, with significant international collaborations.
  • A notable trend shows a shift from endoscopic interventions to pharmacological therapies.
  • Sirolimus demonstrated success in treating colonic angioectasia; keywords like "angiodysplasia," "colon," and "management" were prominent, with growing interest in "thalidomide."

Conclusions:

  • Bibliometric analysis combined with clinical insights reveals a paradigm shift towards pharmacological management.
  • This approach aims to enhance patient outcomes in GI vascular bleeding disorders.
  • The findings underscore the growing importance of drug-based therapies in managing these conditions.
Abstract